Furthermore, in the same study in vitro, data indicated that the amount of fibrillin-1 in the extracellular matrix produced by SSc cells diminished faster than in the matrix of control cells, arguing for a higher susceptibility to proteolytic degradation. The gene discussed is FBN1; the disease is systemic sclerosis.